The time point of about 60 days of tSNS at which the subjects' satisfaction was assessed may not be optimal.
In regard to work shifts, subjects' satisfaction with the morning, evening and night shifts were 62.4%, 64.3% and 63.3%, respectively.
- Inspector 3. Overall, the average degree of the subjects' satisfaction when using the tool was 7.7 (based on the VAS scale in Figure 10), which means that the inspectors were pleased when using the tool.
Subjects' satisfaction with treatment was very high throughout the study.
We defined subjects' satisfaction as the level of positive appreciation for each item of the WHOQOL-Bref [ 29].
Subjects' satisfaction was recorded using a 5-point Likert scale, wherein the scores ranged from 1 (very unsatisfied) to 5 (very satisfied).
Endpoints include procedure-related adverse events, including pneumothorax, bronchopulmonary hemorrhage, and respiratory failure, as well as quality of life, and subject satisfaction.
Subject satisfaction with treatment was based on a 7-point Likert Scale, with 1 being very satisfied and 7 being very dissatisfied.
Level of optimism was weakly correlated with subject satisfaction across all OAB-SAT-q subscales (r value of -0.11, -0.21, -0.42, and -0.20 for satisfaction, endorsement, adverse effects, and convenience, respectively).
Daily diary assessments included onset and duration of headache, severity of pain at the time of onset and at treatment, acute headache pain medication(s) usage, study drug usage, associated symptoms, unusual symptoms, and subject satisfaction with treatment.
Secondary endpoints included pain relief, pain freedom, and headache severity at 30, 60, 90, and 120 min postdose, proportion of subjects with relief of associated migraine symptoms (ie, nausea, photophobia, and phonophobia) at 60 min postdose, subject satisfaction with treatment, and use of rescue medication from 2 to 24 h postdose.
